Publications

Redd, R. et al. (2021) “Behavioural responses to SARS-CoV-2 antibody testing in England: REACT-2 study”, Wellcome Open Research, 6, p. 203.

Williams, L. et al. (2021) “Measuring vaccine efficacy against infection and disease in clinical trials: sources and magnitude of bias in COVID-19 vaccine efficacy estimates”, p. 2021.07.30.21260912.

Ward, H. et al. (2021) “Increasing SARS-CoV-2 antibody prevalence in England at the start of the second wave: REACT-2 Round 4 cross-sectional study in 160,000 adults”, p. 2021.07.21.21260926.

Gold, S. et al. (2021) “Modelling the influence of naturally acquired immunity from subclinical infection on outbreak dynamics and persistence of rabies in domestic dogs”, PLoS Neglected Tropical Diseases, 15(7).

Hillis, S. et al. (2021) “Under the radar: global minimum estimates for COVID-19-associated orphanhood and deaths among caregivers”, Lancet, 398(10298), pp. 391–402.

Dorigatti, I. et al. (2021) “SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo’”, Nature Communications, 12.

Ward, H. et al. (2021) “Vaccine uptake and SARS-CoV-2 antibody prevalence among 207,337 adults during May 2021 in England: REACT-2 study”, p. 2021.07.14.21260497.

Watson, J. et al. (2021) “Improving statistical power in severe malaria genetic association studies by augmenting phenotypic precision”, eLife, 10.

Charniga, K. et al. (2021) “Spatial and temporal invasion dynamics of the 2014–2017 Zika and chikungunya epidemics in Colombia”, PLOS Computational Biology, 17(7), p. e1009174.

Hillis, S. et al. (2021) “Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study.”, Lancet (London, England), 398(10298), pp. 391–402.